Pre-Market Stock Notes (JAN 16, 2007)

(ALTR) Altera signed GE veteran Timothy Morse as its new CFO.
(AMTD) TD Ameritrade trading up 4% pre-market as earnings rose 13%.
(ANPI) Angiotech Pharm says its appeal to reverse a previous decision was denied.
(ARDM) Aradigm received FDA Orphan Drug Designation for Liposomal Ciprofloxacin.
(ARQL) ArQule will explore a continuous dosing schedule prior to initiation of Phase 2 testing with ARQ 197 in the second quarter of 2007 for tumor studies.
(AVR) Aventine Renewable Energy Holdings announces that Indiana Bio-Energy’s Bluffton, IN facility will join its marketing alliance network.
(BCRX) BioCryst Pharm initiates Fodosine Phase IIb clinical trial in patients with relapsed or refractory Leukemia and Lymphoma.
(BIDU) Baidu.com up 2% on pact with EMI Music for streaming music in China.
(CN) China Netcom disposes of telecommunications assets in Guangdong and Shanghai.
(CSCO) Cisco stock trading down 1.25% pre-market on Bank of America downgrade.
(CTSH) Cognizant Tech signs a 5-yr, multi-million dollar agreement with Kimberly-Clark.
(CTX) Centex lowered guidance again, now see $0.75 EPS vs $0.81 est.
(DDSS) Labopharm response to approvable letter for once-daily tramadol as complete accepted for review at the FDA.
(ELK) ElkCorp amends merger agreement with the Carlyle Group to $40.50 per share.
(EPEX) Edge Petroleum filed to sell 9.2M shares of Common Stock.
(ERJ) Embraer SA increases delivery forecast for 2007.
(ESRX) Express Scripts sets $56.87 as CVS value in share exchange.
(FTI) FMC Technologies to supply subsea systems for Woodside Energy’s Vincent project.
(GDP) Goodrich Petroleum to sell South Louisiana assets for roughly $100 million.
(GE) GE is acquiring Smiths Aerospace unit.
(HEPH) Hollis-Eden says data suggests HE3286 acts through new mechanism in Type 2 Diabetes.
(HW) Headwaters raised guidance; but filed to sell $125M in Convertible Senior Notes.
(HNAB) Hana Biosciences received orphan drug status from FDA for Mariqibo.
(KONG) KongZhong appoints new Chief Financial Officer.
(KSWS) K-Swiss shoes noted as looking cheap, but is just a value trap and therefore a Sell according to Cramer on MAD MONEY.
(MIVA) MIVA signs pay-per-click contract with Johnston Press.
(MNRO) Monroe Muffler $0.32 EPS vs $0.32 est.
(MRVC) MRV Communications up on Cramer’s “speculative stock” play.
(NDE) IndyMac substantially lowered guidance.
(NFLX) Netflix adds on online video viewing to DVD rental service plans.
(NKE) Nike touted as Best of breed over K-Swiss on Cramer’s MAD MONEY.
(NTY) NBTY preliminary revenues were $506 Million instead of $497.5 million.
(OSIR) Osiris Therapeutics receives Orphan Drug designation for PROCHYMAL in the European Union.
(PVTB) PrivateBancorp $0.42 EPS vs $0.46e.
(PWEI) J-M Manufacturing and PW Eagle announced definitive merger agreement for $33.50 per PWEI share.
(QSFT) Quest Software special committee reports findings of stock option investigation and will have charges as result of backdated options.
(RIMM) R-I-M issued additional filing regarding last Q2 and Q3 beyond last year’s filings.
(SRZ) Sunrise Senior Living has said its review is still continuing regarding a restatement
(TRCA) Tercica’s Somatuline Autogel application filing accepted by the FDA.
(VTR) Ventas making $1.8 Billion offer for Sunrise Senior Living REITR in Canada.

Contact [email protected] for any questions or corrections.